Latest Breaking News On - Jan dalvise - Page 8 : comparemela.com

Acasti Pharma unveils proposal to buy Grace Therapeutics and its portfolio of drug candidates in all-stock deal Acasti will acquire Grace’s entire therapeutic pipeline consisting of three unique clinical stage and multiple preclinical stage assets, supported by an intellectual property portfolio of more than 40 granted and pending patents Both companies boards have approved the deal thus far, as have Grace stockholders Acasti Pharma Inc (NASDAQ:ACST) (CVE:ACST) has announced a definitive agreement to acquire Grace Therapeutics Inc, a privately-held biopharmaceutical company developing drug delivery technologies for the treatment of rare and orphan diseases.  The deal would have Acasti acquire Grace’s entire therapeutic pipeline consisting of three unique clinical stage and multiple preclinical stage assets, supported by an intellectual property portfolio of more than 40 granted and pending patents globally. Both companies  boards have approved the deal thus far

Roddy carterVimal kavuruJan dalviseGrace therapeutics incUs food drug administrationOrphan drug designationDrug administrationNew drug applicationChairman roddy carterChairman vimal kavuruஆர்ஃபந் மருந்து பதவிபுதியது மருந்து விண்ணப்பம்